Organizations

Pfizer Canada ULC

Pfizer Canada ULC has met with MPs 21 times since January 2024, reaching 15 MPs across 2 parties. Most recent contact: June 17, 2026.

21 meetings since 202482 all-time15 MPs2 parties100% by in-house staff

What they're asking for

In the registry's own words. Descriptions are only filed for meetings since mid-2024.

  1. Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations.

    June 17, 2026 · Marjorie Michel · Liberal · Government Procurement; Health; Industry; Intellectual Property; International Trade

  2. Advocacy related to the new Buy Canada policy and the implications of including goods and services related to healthcare delivery, medical treatment, in particular drugs, vaccines and biologicals.

    June 12, 2026 · Mélanie Joly · Liberal · Government Procurement; Health; Industry; Intellectual Property; International Trade

  3. Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes.

    April 15, 2026 · Maggie Chi · Liberal · Government Procurement; Health; Industry; Intellectual Property; International Trade

  4. Engage the Federal Government on Health Canada’s Regulatory Innovation Agenda (Agile Licensing Modernization) to discuss opportunities for further harmonization; flexibility and predictability in the new regulatory framework being develop and its linkage to pillar 5 of the Biomanufacturing and Life Sciences Strategy.

    February 23, 2026 · Karim Bardeesy · Liberal · Government Procurement; Health; Industry; Intellectual Property; International Trade

  5. Monitoring and engaging the Government and Parliamentarians on policies and programs related to Canada's life sciences & biomanufacturing strategy

    December 5, 2025 · Jean-Yves Duclos · Liberal · Government Procurement; Health; Industry; Intellectual Property; International Trade

  6. Advocacy with respect to Canada's proposed Countermeasures in Response to United States Tariffs on Canadian goods

    October 21, 2025 · Peter Fonseca · Liberal · Government Procurement; Health; Industry; Intellectual Property; International Trade

  7. Contribution to the Government Public consultations on Canada-United States-Mexico Agreement to inform Canada’s priorities in preparation for the first joint review of CUSMA by Canada, the United States and Mexico in 2026 and ahead of Canada’s chairing of the 5th meeting of the CUSMA Free Trade Commission, in 2025.

    September 8, 2025 · Adam Chambers · Conservative · Health; Industry; Intellectual Property; International Trade; Research and Development

Full meeting log

21 MP-directed communications since January 2024, from the Registry of Lobbyists.

DateMP
2026-06-17Marjorie Michel · Liberal
2026-06-12Mélanie Joly · Liberal
2026-04-15Maggie Chi · Liberal
2026-04-02Marjorie Michel · Liberal
2026-02-23Karim Bardeesy · Liberal
2026-02-23Dominic LeBlanc · Liberal
2026-02-23Marjorie Michel · Liberal
2025-12-05Jean-Yves Duclos · Liberal
2025-12-05Steeve Lavoie · Liberal
2025-12-05Marjorie Michel · Liberal
2025-10-23Ali Ehsassi · Liberal
2025-10-23Randy Hoback · Conservative
2025-10-23Shelby Kramp-Neuman · Conservative
2025-10-23Dominic LeBlanc · Liberal
2025-10-21Peter Fonseca · Liberal
2025-09-08Adam Chambers · Conservative
2024-09-23Peter Fragiskatos · Liberal
2024-05-23Blaine Calkins · Conservative
2024-05-23Tom Kmiec · Conservative
2024-04-15Randy Hoback · Conservative
2024-02-01Randy Hoback · Conservative
Counts include only communications where a sitting MP is the named public office holder — meetings with ministers' staff, senators, or departments are not shown. Registrants self-report these records. See our methodology.